Do predictive signatures really predict response to cancer chemotherapy?
Open Access
- 15 December 2010
- journal article
- review article
- Published by Informa UK Limited in Cell Cycle
- Vol. 9 (24), 4836-4840
- https://doi.org/10.4161/cc.9.24.14326
Abstract
Predictive signatures are gene expression profiles that should predict the response of tumors to chemotherapy in patients. Such signatures have been derived from the response of tumor cell lines to chemotherapy, but their usefulness in patients remains controversial, as the most spectacular published signatures are based on unreliable data. We discuss why it is difficult to derive meaningful predictive signatures from cell line panels and we argue that it is implausible that fully predictive signatures can be obtained for classical chemotherapy from oligo-based gene expression arrays. One reason is that resistance to chemotherapy can be caused by alterations in (the expression of) a single gene. We do not expect that such subtle alterations will be reliably picked up by standard gene expression profiling. We delineate alternative approaches that should be able to yield predictive markers that can be used for optimizing patient treatment.Keywords
This publication has 59 references indexed in Scilit:
- The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive modelsNature Biotechnology, 2010
- New class of gene-termini-associated human RNAs suggests a novel RNA copying mechanismNature, 2010
- NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease OutcomeCell, 2010
- Genome remodelling in a basal-like breast cancer metastasis and xenograftNature, 2010
- Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancerNature Medicine, 2010
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLCCancer Cell, 2010
- The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancerBreast Cancer Research and Treatment, 2009
- A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancerNature Medicine, 2009
- Genomic signatures to guide the use of chemotherapeuticsNature Medicine, 2006
- Metastasis genes: A progression puzzleNature, 2002